Viirman, Frida
Hesselman, Susanne
Poromaa, Inger Sundström
Svanberg, Agneta Skoog
Wikman, Anna
Funding for this research was provided by:
Födelsefonden
Stiftelsen Uppsala Sjuksköterskehem
Uppsala University
Article History
Received: 2 January 2023
Accepted: 6 March 2023
First Online: 14 March 2023
Declarations
:
: Ethical approval for the study was obtained from The Swedish Ethical Review Authority, Dnr 2019–06534, amendment 2020–05397 and 2021–03580. The procedures used in this study adhered to the tenets of the Declaration of Helsinki and were carried out in accordance with relevant guidelines and regulations. Informed consent was obtained from all participants.
: Not applicable.
: Over the past five years, Inger Sundström Poromaa has occasionally served on advisory boards or been an invited speaker at scientific meetings for Bayer Health Care, Gedeon Richter, Sandoz and Novartis outside the submitted work. The other authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.